The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Lexeo Therapeutics Inc shares valued at $19,557 were sold by Townsend Richard Nolan on Nov 11 ’24. At $7.82 per share, Townsend Richard Nolan sold 2,500 shares. The insider’s holdings dropped to 120,695 shares worth approximately $0.92 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Townsend Richard Nolan sold 5,000 shares, netting a total of over 40,496 in proceeds. Following the sale of shares at $8.10 each, the insider now holds 120,695 shares.
Before that, Townsend Richard Nolan had sold 5,000 shares from its account. In a trade valued at $53,274, the Chief Executive Officer traded Lexeo Therapeutics Inc shares for $10.65 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $0.92 million.
As published in their initiating research note from Robert W. Baird on June 13, 2024, Lexeo Therapeutics Inc [LXEO] has been an Outperform and the price target has been revised to $28. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of November 28, 2023, Stifel has initiated its “Buy” rating for LXEO. Earlier on November 28, 2023, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for LXEO stock.
Analyzing LXEO Stock Performance
During the last five days, there has been a drop of approximately -6.83%. Over the course of the year, Lexeo Therapeutics Inc shares have dropped approximately -43.07%. Shares of the company reached a 52-week high of $22.33 on 01/18/24 and a 52-week low of $7.47 on 11/12/24. A 50-day SMA is recorded $9.16, while a 200-day SMA reached $12.99. Nevertheless, trading volume fell to 5.96 million shares from 0.18 million shares the previous day.
Support And Resistance Levels for Lexeo Therapeutics Inc (LXEO)
According to the 24-hour chart, there is a support level at 6.28, which, if violated, would cause prices to drop to 4.92. In the upper region, resistance lies at 10.36. The next price resistance is at 13.08. RSI (Relative Strength Index) is 37.62 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.60, which suggests the price will decrease in the coming days. Percent R is at 96.00%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
